The Claim
The mutation signature SBS-pks, resulting from colibactin-induced DNA damage, can be reliably detected in clinical tumor samples using the targeted sequencing assay MSK-IMPACT, allowing for the identification of this bacterial mutagenesis pattern without the need for whole-genome sequencing.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A specific pattern of DNA damage caused by a bacterial toxin can be identified in tumor samples using a targeted DNA sequencing test called MSK-IMPACT, without needing to sequence the entire genome.
See the scientific wording
The mutation signature SBS-pks, caused by colibactin-induced DNA damage, can be reliably detected in clinical tumor samples using the targeted sequencing assay MSK-IMPACT, enabling identification of this bacterial mutagenesis pattern without requiring whole-genome sequencing.
What the research says
1 studyScientists found a way to spot a specific DNA damage pattern caused by a gut bacteria using a common cancer test (MSK-IMPACT) that hospitals already use—no need for expensive full genome scans. This means doctors can now detect this bacterial damage in patients using routine tests.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.